
Keywords: aCL, Anticardiolipin antibody; aPL, Antiphospholipid antibody; apoER2, Apolipoprotein E receptor 2; aPS/PT, Anti-phosphatidylserine/prothrombin antibody; APS, Antiphospholipid syndrome; CAPS, Catastrophic antiphospholipid syndrome; CCP, Complement control